Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
[Insomnia in children and adolescents. A consensus document]
Gonzalo Pin Arboledas1, Víctor Soto Insuga2, María José Jurado Luque3
1Asociación Española de Pediatría (AEP).
Insights
Childhood insomnia affects learning and family well-being, impacting 30% of young children. This consensus highlights clinical diagnosis and cognitive-behavioral therapy as primary treatments for pediatric sleep issues.
Area of Science:
- Pediatrics
- Sleep Medicine
- Child Psychology
Background:
- Childhood insomnia is prevalent, affecting up to 30% of children under five.
- Sleep disturbances in children lead to significant cognitive, emotional, and learning deficits.
- Pediatrician training in diagnosing and managing childhood insomnia is often inadequate.
Framework:
- A consensus document on managing childhood and adolescent insomnia.
- Developed by leading Spanish pediatric and sleep medicine societies.
- Emphasizes clinical diagnosis, reserving tests for complex cases.
Implementation:
- Primary treatment focuses on cognitive-behavioral therapy (CBT).
- Behavioral interventions include modifying sleep habits.
- Discourages the use of medications without clear clinical guidelines.
Implications:
- Improved diagnostic and treatment protocols for pediatric insomnia.
- Enhanced quality of life for children and their families.
- Addresses the gap in clinical guidelines for pharmacotherapy in pediatric sleep disorders.
Abstract:
Insomnia is very common during childhood (30% of children under 5), and causes a serious cognitive and emotional consequence in learning, as well as significant medical comorbidity. It also affects the quality of life, not only of the child, but also of the whole family. Paediatrician training in its diagnosis and treatment is usually poor. For this reason a consensus document is presented on the management of insomnia in children and adolescents. This has been developed by members of the Spanish Paediatrics Association, the Spanish Sleep Society, the Spanish Society of Paediatric Outpatient and Primary Care, the Spanish Adolescent Medicine Society, the Spanish Child and Adolescent Society, and the Spanish Paediatric Neurology Society. The group suggests that diagnosis must be clinical and complementary tests will only be required in doubtful cases or when a differential diagnosis is needed. Likewise, treatment should be mainly based on cognitive-behavioural therapy and the modification of sleeping habits. Using medicines and other substances to make the sleep easier is currently quite common, even although there are no clinical guidelines to support this.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Nightmares and Night Terrors
Nightmares...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

